Bharat Parenterals Ltd

NSE: BSE: 541096

₹1142.50

(3.67%)

Wed, 11 Mar 2026, 07:31 am

MTF 5xInvest in Bharat Parenterals Ltd with 5x Leverage Buy with MTF

Market Cap7.87B

PE Ratio0

Dividend0.09

Health Technology

Pharmaceuticals: Major

24.5K

Company History

1992

Bhaarat Parenterals was incorporated on 3rd September under part IX of the Companies Act 1956.
The company obtained the certificate of Commencement of Business from the Registrar of Companies, Gujarat, Ahmedabad on 9th September.

2021

The company received the license and authorization from the Drugs Controller General of India and Central Drugs Standard Control Organisation for manufacturing and marketing Favipiravir Oral Suspension 100Mg/Ml.

2025

Bharat Parenterals completed the Paraguay Audit in April.
Bharat Parenterals received the Resilient Award from the Southern Gujarat Chamber of Commerce & Industry.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800